Ausgabe 9/2018
Topical Issue on Brain Imaging / Including the Special Section: Diagnostic Utility of FDG-PET in Dementia: Literature Evidence and Expert Opinion
Inhalt (17 Artikel)
Brain FDG-PET: clinical use in dementing neurodegenerative conditions
Flavio Nobili, Reinhold Schmidt, Ignasi Carriò, Giovanni B. Frisoni
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
Marina Boccardi, Cristina Festari, Daniele Altomare, Federica Gandolfo, Stefania Orini, Flavio Nobili, Giovanni B. Frisoni, Federica Agosta, Javier Arbizu, Femke Bouwman, Alexander Drzezga, Peter Nestor, Zuzana Walker
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
Alexander Drzezga, Daniele Altomare, Cristina Festari, Javier Arbizu, Stefania Orini, Karl Herholz, Peter Nestor, Federica Agosta, Femke Bouwman, Flavio Nobili, Zuzana Walker, Giovanni Battista Frisoni, Marina Boccardi
Clinical utility of FDG-PET for the clinical diagnosis in MCI
Javier Arbizu, Cristina Festari, Daniele Altomare, Zuzana Walker, Femke Bouwman, Jasmine Rivolta, Stefania Orini, Henryk Barthel, Federica Agosta, Alexander Drzezga, Peter Nestor, Marina Boccardi, Giovanni Battista Frisoni, Flavio Nobili
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
Peter J. Nestor, Daniele Altomare, Cristina Festari, Alexander Drzezga, Jasmine Rivolta, Zuzana Walker, Femke Bouwman, Stefania Orini, Ian Law, Federica Agosta, Javier Arbizu, Marina Boccardi, Flavio Nobili, Giovanni Battista Frisoni
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
Femke Bouwman, Stefania Orini, Federica Gandolfo, Daniele Altomare, Cristina Festari, Federica Agosta, Javier Arbizu, Alexander Drzezga, Peter Nestor, Flavio Nobili, Zuzana Walker, Silvia Morbelli, Marina Boccardi
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
Zuzana Walker, Federica Gandolfo, Stefania Orini, Valentina Garibotto, Federica Agosta, Javier Arbizu, Femke Bouwman, Alexander Drzezga, Peter Nestor, Marina Boccardi, Daniele Altomare, Cristina Festari, Flavio Nobili
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease
Federica Agosta, Daniele Altomare, Cristina Festari, Stefania Orini, Federica Gandolfo, Marina Boccardi, Javier Arbizu, Femke Bouwman, Alexander Drzezga, Peter Nestor, Flavio Nobili, Zuzana Walker, Marco Pagani
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
Flavio Nobili, Cristina Festari, Daniele Altomare, Federica Agosta, Stefania Orini, Koen Van Laere, Javier Arbizu, Femke Bouwman, Alexander Drzezga, Peter Nestor, Zuzana Walker, Marina Boccardi
18F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy
Yao Ding, Yuankai Zhu, Biao Jiang, Yongji Zhou, Bo Jin, Haifeng Hou, Shuang Wu, Junming Zhu, Zhong Irene Wang, Chong H. Wong, Meiping Ding, Hong Zhang, Shuang Wang, Mei Tian
Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas
Manuel Röhrich, Kristin Huang, Daniel Schrimpf, Nathalie L. Albert, Thomas Hielscher, Andreas von Deimling, Ulrich Schüller, Antonia Dimitrakopoulou-Strauss, Uwe Haberkorn
The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage
Han Soo Yoo, Seok Jong Chung, Soo-Jong Kim, Jung Su Oh, Jae Seung Kim, Byoung Seok Ye, Young Ho Sohn, Phil Hyu Lee
Quantitative evaluation of tau PET tracers 18F-THK5351 and 18F-AV-1451 in Alzheimer’s disease with standardized uptake value peak-alignment (SUVP) normalization
Jingyun Chen, Yi Li, Elizabeth Pirraglia, Nobuyuki Okamura, Henry Rusinek, Mony J. de Leon
Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain
Konstantinos Chiotis, Per Stenkrona, Ove Almkvist, Vladimir Stepanov, Daniel Ferreira, Ryosuke Arakawa, Akihiro Takano, Eric Westman, Andrea Varrone, Nobuyuki Okamura, Hitoshi Shimada, Makoto Higuchi, Christer Halldin, Agneta Nordberg
Noradrenaline transporter availability on [11C]MRB PET predicts weight loss success in highly obese adults
Franziska J. Vettermann, Michael Rullmann, Georg A. Becker, Julia Luthardt, Franziska Zientek, Marianne Patt, Philipp M. Meyer, Anke McLeod, Matthias Brendel, Matthias Blüher, Michael Stumvoll, Anja Hilbert, Yu-Shin Ding, Osama Sabri, Swen Hesse
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience
Garry Ceccon, Lazaros Lazaridis, Gabriele Stoffels, Marion Rapp, Manuel Weber, Tobias Blau, Phillip Lohmann, Sied Kebir, Ken Herrmann, Gereon R. Fink, Karl-Josef Langen, Martin Glas, Norbert Galldiks
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue
Leszek Krolicki, Frank Bruchertseifer, Jolanta Kunikowska, Henryk Koziara, Bartosz Królicki, Maciej Jakuciński, Dariusz Pawlak, Christos Apostolidis, Saed Mirzadeh, Rafał Rola, Adrian Merlo, Alfred Morgenstern